Rebalancing the Immune System to Treat Type 1 Diabetes
Cold Spring Harbor Perspectives in Medicine · 2025
DOI: 10.1101/cshperspect.a041599 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cold Spring Harbor Perspectives in Medicine, 2025. Verfasst von Yannick D Muller und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, 1005 Lausanne, Switzerland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
In type 1 diabetes (T1D), the immune system mistakenly attacks the pancreatic islet β cells resulting in the loss of insulin secretion. Insulin-replacement therapy developed more than a century ago provided means to manage the symptoms of diabetes without addressing the root cause of the disease-the faulty immune system. A healthy immune system has built-in mechanisms to limit unwanted, excessive immune activation and prevents damages to self-tissues. These immune self-tolerance mechanisms are often impaired in autoimmune patients including those with T1Ds. Understanding how immune self-tolerance is broken in patients with T1D can inform the design of new curative therapies that correct the immune defects. In this paper, we will summarize the mechanisms of immune tolerance, review their relevance to T1Ds, and discuss novel therapeutic approaches to rebalance the immune system for the treatment of T1Ds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, 1005 Lausanne, Switzerland.
- Center for Human Immunology Lausanne, Lausanne University Hospital and University of Lausanne, 1005 Lausanne, Switzerland.
- Diabetes Center, University of California San Francisco, San Francisco, California 94143, USA.
- Sonoma Biotherapeutics, South San Francisco, California 94080, USA.
- Diabetes Center, University of California San Francisco, San Francisco, California 94143, USA Qizhi.Tang@ucsf.edu.
- Department of Surgery, Division of Transplantation, University of California San Francisco, San Francisco, California 94143, USA.
ORCID-Profile: Yannick D Muller, Qizhi Tang
Förderung
- NIAID NIH HHS
Zitieren
APA
Muller, Y. D., Ho, P., Bluestone, J. A., & Tang, Q. (2025). Rebalancing the Immune System to Treat Type 1 Diabetes. Cold Spring Harbor Perspectives in Medicine. https://doi.org/10.1101/cshperspect.a041599
Vancouver
Muller YD, Ho P, Bluestone JA, Tang Q. Rebalancing the Immune System to Treat Type 1 Diabetes. Cold Spring Harbor Perspectives in Medicine. 2025. doi:10.1101/cshperspect.a041599
BibTeX
@article{Muller2025,
author = {Muller, Yannick D and Ho, Patrick and Bluestone, Jeffrey A and Tang, Qizhi},
title = {Rebalancing the Immune System to Treat Type 1 Diabetes},
journal = {Cold Spring Harbor Perspectives in Medicine},
year = {2025},
doi = {10.1101/cshperspect.a041599}
}
EUVIMED